- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Life Technologies Corp
+ Add to WatchlistLIFE:US
73.9400 USD 0.1600 0.22%As of 20:10:00 ET on 05/23/2013.
Snapshot for Life Technologies Corp (LIFE)
| Open: | 74.0000 | Day's Range: | 73.8900 - 74.0900 | Volume: | 2,967,855 |
|---|---|---|---|---|---|
| Previous Close: | 73.9400 | 52wk Range: | 39.7300 - 74.3300 | 1-Yr Rtn: | +76.01% |
Key Statistics for LIFE
| Current P/E Ratio (ttm) | 24.9538 |
|---|---|
| Estimated P/E(12/2013) | 17.4593 |
| Relative P/E vs. SPX | 1.5489 |
| Earnings Per Share (USD) (ttm) | 2.9631 |
| Est. EPS (USD) (12/2013) | 4.2350 |
| Est. PEG Ratio | 1.8330 |
| Market Cap (M USD) | 12,723.39 |
| Shares Outstanding (M) | 172.08 |
| 30 Day Average Volume | 5,706,386 |
| Price/Book (mrq) | 2.7044 |
| Price/Sale (ttm) | 3.3612 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LIFE
Company Profile & Key Executives for LIFE
Life Technologies Corporation develops biotechnology tools used by researchers. The Company offers a broad range of products and services, including systems, instruments, reagents, and custom services. Life's portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry sample preparation, and cell culture.
| Gregory T LucierChairman/CEO | Mark P StevensonPresident/COO |
| Ronald A Andrews Jr "Ronnie"President:Medical Sciences | David F HoffmeisterChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
LIFE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page